BEPANTHEN MED ong nasal 50 mg/g 2 tb 5 g
7680455350016
CH-45535
R01AX10
12.02.4.
1 / 3
google
Details
- Product number
- 4553501
- CPT
- -
- Packaging group
- 2 x 5
- Unit
- g
- Composition
- dexpanthenolum 50 mg, dl-pantolactonum, adeps lanae 100 mg, vaselinum album, paraffinum liquidum, aqua purificata, q.s. ad unguentum pro 1 g.
Articles (1)
Bepanthen MED, Nasensalbe
Nasensalbe
2 x 5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
100.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Bayer (Schweiz) AG
8045 Zürich
Authorization information
- Swissmedic authorization number
- 45535
- Drug name
- Bepanthen MED, Nasensalbe
- Galenic form
- NASA
- ATC Code
- R01AX10
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 08/09/1983
- Authorization expiration date
- 31/12/9999
- IT number
- 12.02.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BEPANTHEN MED ong nasal 50 mg/g 2 tb 5 g
- Description (DE)
- BEPANTHEN MED Nasensalbe 50 mg/g 2 Tb 5 g
- Market launch
- 08/09/1983
- Narcotic (BTM)
- No